NCT02101853-D1
Dataset Information
Dataset ID: NCT02101853-D1
PubMed ID (PMID):
Publication Title:
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Description of Dataset:
NCT02101853-D1: There are a total of 2 datasets associated with the PubMed 33651090: NCT02101853-D1 through NCT02101853-D2. This dataset, NCT02101853-D1,
provides the information of consort flow of patient enrollment, baseline characteristics, MRD (minimal residual disease) negativity, transplant status, adverse event status in each course, and primary outcome for the patients on AALL1331 as reported in the manuscript. There is one row for each patient enrolled.
provides the information of consort flow of patient enrollment, baseline characteristics, MRD (minimal residual disease) negativity, transplant status, adverse event status in each course, and primary outcome for the patients on AALL1331 as reported in the manuscript. There is one row for each patient enrolled.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT02101853 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®